Tema Etfs LLC Has $3.32 Million Position in CME Group Inc. $CME

Tema Etfs LLC grew its stake in shares of CME Group Inc. (NASDAQ:CME) by 78.2% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 12,298 shares of the financial services provider’s stock after buying an additional 5,396 shares during the period. Tema Etfs LLC’s holdings in CME Group were worth $3,323,000 as of its most recent filing with the SEC.

Other institutional investors have also added to or reduced their stakes in the company. Webster Bank N. A. lifted its position in shares of CME Group by 206.9% in the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 60 shares during the period. Caldwell Trust Co increased its position in shares of CME Group by 116.3% during the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 50 shares during the period. Highline Wealth Partners LLC raised its stake in shares of CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 43 shares in the last quarter. Financial Consulate Inc. bought a new position in CME Group in the third quarter worth $28,000. Finally, Sagard Holdings Management Inc. bought a new position in CME Group in the second quarter worth $30,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director William R. Shepard purchased 251 shares of CME Group stock in a transaction that occurred on Tuesday, December 30th. The shares were acquired at an average price of $278.37 per share, for a total transaction of $69,870.87. Following the transaction, the director directly owned 258,710 shares in the company, valued at approximately $72,017,102.70. This represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $263.53, for a total transaction of $263,530.00. Following the sale, the director directly owned 1,091 shares in the company, valued at approximately $287,511.23. This represents a 47.82% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.30% of the company’s stock.

CME Group Price Performance

NASDAQ:CME opened at $262.45 on Monday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm has a market cap of $94.64 billion, a PE ratio of 25.43, a price-to-earnings-growth ratio of 3.39 and a beta of 0.27. CME Group Inc. has a 12 month low of $225.46 and a 12 month high of $290.79. The company’s 50-day moving average price is $273.95 and its two-hundred day moving average price is $271.88.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. The company had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. CME Group’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.68 earnings per share. On average, equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th were paid a $1.25 dividend. The ex-dividend date of this dividend was Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. CME Group’s payout ratio is currently 48.45%.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Morgan Stanley boosted their price target on shares of CME Group from $314.00 to $320.00 and gave the company an “overweight” rating in a report on Monday, December 22nd. Jefferies Financial Group dropped their price target on shares of CME Group from $313.00 to $304.00 and set a “buy” rating for the company in a research report on Friday, October 10th. JPMorgan Chase & Co. raised their price target on shares of CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research note on Tuesday, October 14th. Argus decreased their price objective on CME Group from $308.00 to $295.00 in a report on Friday, October 31st. Finally, UBS Group reissued a “neutral” rating on shares of CME Group in a report on Tuesday, January 6th. Eight equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $291.06.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.